# INSYS Therapeutics Inc clinical trials: 45 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 45 trials with INSYS Therapeutics Inc as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by INSYS Therapeutics Inc: 45 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/insys-therapeutics-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 45
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 45, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 1, 2019 | NCT03827642 | A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM)... | INSYS Therapeutics Inc | Phase 1 | Completed | Healthy Volunteer | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03827642) |
| February 1, 2019 | NCT03827629 | A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Injection (IM) in Healthy... | INSYS Therapeutics Inc | Phase 1 | Completed | Healthy Volunteer | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03827629) |
| August 18, 2017 | NCT03254459 | Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain | INSYS Therapeutics Inc | Phase 2 | Completed | Pain, Postoperative | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03254459) |
| September 27, 2016 | NCT02915978 | Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain | INSYS Therapeutics Inc | Phase 2 | Completed | Pain | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02915978) |
| December 29, 2015 | NCT02641340 | Fentanyl Sublingual Spray in Opioid Naive Participants | INSYS Therapeutics Inc | Phase 1 | Completed | Pharmacology | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02641340) |
| December 18, 2015 | NCT02634788 | Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain | INSYS Therapeutics Inc | Phase 3 | Completed | Pain | 322 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02634788) |
| November 16, 2015 | NCT02604992 | Comparative Bioavailability of Dronabinol Oral Solution in Healthy Volunteers | INSYS Therapeutics Inc | Not applicable | Completed | Healthy | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02604992) |
| October 15, 2015 | NCT02576353 | Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects | INSYS Therapeutics Inc | Phase 1 | Completed | Pharmacokinetics and Pharmacodynamics | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02576353) |
| September 16, 2015 | NCT02551731 | Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms | INSYS Therapeutics Inc | Phase 2 | Terminated | Spasms, Infantile | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02551731) |
| June 22, 2015 | NCT02477267 | Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers | INSYS Therapeutics Inc | Phase 1 | Completed | Opiate Dependence | 47 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02477267) |
| December 24, 2014 | NCT02324673 | Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders | INSYS Therapeutics Inc | Phase 1/2 | Completed | Seizures | 61 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02324673) |
| December 17, 2014 | NCT02318602 | Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder | INSYS Therapeutics Inc | Phase 3 | Completed | Seizures | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02318602) |
| December 17, 2014 | NCT02318563 | Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome | INSYS Therapeutics Inc | Phase 3 | Withdrawn | Dravet Syndrome | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02318563) |
| December 17, 2014 | NCT02318537 | Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome | INSYS Therapeutics Inc | Phase 3 | Withdrawn | Lennox-Gastaut Syndrome | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02318537) |
| December 8, 2014 | NCT02310581 | Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain | INSYS Therapeutics Inc | Phase 3 | Terminated | Post-operative Pain | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02310581) |
| May 14, 2014 | NCT02138409 | Fentanyl Sublingual Spray for the Treatment of Acute Procedure-related Pain in a Monitored Setting | INSYS Therapeutics Inc | Phase 3 | Withdrawn | Chronic Pain | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02138409) |
| May 14, 2014 | NCT02138396 | Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions | INSYS Therapeutics Inc | Not applicable | Completed | Bioavailability | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02138396) |
| May 14, 2014 | NCT02137525 | Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain | INSYS Therapeutics Inc | Phase 2 | Withdrawn | Acute Pain | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02137525) |
| March 24, 2014 | NCT02094599 | A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users | INSYS Therapeutics Inc | Phase 1 | Completed | Drug Abuse, Medication | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02094599) |
| April 16, 2013 | NCT01832974 | Possible New Therapy for Advanced Cancer | INSYS Therapeutics Inc | Phase 1 | Terminated | Adrenocortical Carcinoma | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01832974) |
| January 31, 2013 | NCT01780233 | Pharmacokinetic Study of Fentanyl 400 µg Sublingual Spray, Actiq® 400 µg Transmucosally, and Fentanyl Citrate Injection 100 µg... | INSYS Therapeutics Inc | Phase 1 | Completed | Pain | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01780233) |
| October 7, 2011 | NCT01448772 | Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions | INSYS Therapeutics Inc | Phase 1 | Completed | Bioavailability | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01448772) |
| August 30, 2010 | NCT01190982 | Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast Cancer | INSYS Therapeutics Inc | Phase 2 | Completed | Breast Cancer | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01190982) |
| August 25, 2010 | NCT01188408 | Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer | INSYS Therapeutics Inc | Phase 2 | Withdrawn | Prostate Cancer | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01188408) |
| August 23, 2010 | NCT01186731 | Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer | INSYS Therapeutics Inc | Phase 2 | Completed | Pancreatic Cancer | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01186731) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 22 |
| Phase 1/2 | 4 |
| Phase 2 | 7 |
| Phase 3 | 10 |
| Not applicable | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 34 |
| Withdrawn | 8 |
| Terminated | 3 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Neoplasms | 12 |
| Glioma | 8 |
| Glioblastoma | 7 |
| Pain | 6 |
| Astrocytoma | 6 |
| Brain Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Pain, Postoperative | 3 |
| Recurrence | 3 |
| Oligodendroglioma | 2 |
| Adrenocortical Carcinoma | 2 |
| Pancreatic Neoplasms | 2 |
| Breast Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Epilepsies, Myoclonic | 2 |
| Seizures | 2 |
| Lennox Gastaut Syndrome | 2 |
| Congenital Abnormalities | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Leukemia, Myeloid, Accelerated Phase | 1 |
| Blast Crisis | 1 |
| Leukemia, Myelomonocytic, Chronic | 1 |
| Leukemia, Myeloid, Chronic-Phase | 1 |
| Burkitt Lymphoma | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Retaining wall suppliers in the United States](https://specstream.ai/data/businesses/retaining-wall-suppliers/united-states)
- [Vegan restaurants in the United States](https://specstream.ai/data/businesses/vegan-restaurants/united-states)
- [B2B science and technology companies in the United States](https://specstream.ai/data/businesses/b2b-science-and-technology-companies/united-states)
- [Cosmetic surgery practices in the United States](https://specstream.ai/data/businesses/cosmetic-surgery-practices/united-states)
- [Forklift dealers in the United States](https://specstream.ai/data/businesses/forklift-dealers/united-states)
- [Laser cutting companies in the United States](https://specstream.ai/data/businesses/laser-cutting-companies/united-states)
